New birth control shot could last for months
NCT ID NCT04143659
Summary
This is an early study testing a new long-acting injectable birth control called Levonorgestrel Butanoate (LB). Researchers are enrolling about 136 healthy women to find the safest and most effective dose and injection method (into the muscle or under the skin). The main goal is to see how long the drug stays in the body and how well it prevents ovulation, with follow-up lasting about nine months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center Corporation
Boston, Massachusetts, 02118, United States
-
Columbia University
New York, New York, 10032, United States
-
Comprehensive Women's Health Center
Denver, Colorado, 80230, United States
-
Eastern Virginia Medical School
Norfolk, Virginia, 23507, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
University of California, Davis
Davis, California, 95817, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.